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Stathmin is a 19 kDa phosphoprote~, and is proposed to play a role in signai ~~~u~tion in response to various extracellular stimuli that promote 
cellular growth and/or differentiation. We examined stathmin mRNA expression during development and liver regeneration in mice. Stathmin 
mRNA expression declined during the post-natal period and was undetected in adult liver. 36 h after partial hepatectomy, stathmin mRNA was 
rapidly induced and remained at elevated levels for at least 10 days. In situ hybridization experiments confirmed that stathmin mRNA expression 
occurred in hepatocytes. These results indicate that the stathmin gene expression appears to be repressed uring the post-natal iver development, 
and is de-repressed by liver regeneration, which suggests that stathmin may be a good molecular marker of liver plasticity. 
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1. INTRODUCTION 
Stathmin (also designated ~19, oncoprotein 18, pp17, 
pp20, prosolin, 19 K, and leukemia-associated phos- 
phoprotein, Lap18) is a 19 kDa cytoplasmic phospho- 
protein the phosphorylation of which is tightly corre- 
lated with the stimulation of cellular growth and differ- 
entiation [l-6]. It has been proposed that stathmin plays 
a general role as an intracellular signal-relay molecule 
integrating diverse signals regulating cellular prolifera- 
tion and differentiation [1,2]. Stathmin is a member of 
a gene family [7-91 that includes a neuronal-specific 
isoform, SCGlO [IO]. In contrast to neural-restricted 
SCGlO expression, stat~in expression is ubiq~tous 
and its protein and mRNA are found in a wide variety 
of tissues during development and adult life [3,4,9], but 
are not detected in mouse, rat [3,4] or Xenopus [8] liver. 
The mature liver is a post-mitotic tissue, and liver 
proliferation can be induced by surgical or chemical 
treatments that damage a large percentage of hepatic 
parenchyma [111. Parenchyma loss rapidly induces cel- 
lular proliferation in an effort to restore liver mass. 
Since stathmin expression is associated with cellular 
proliferation [12-141, we hypothesized that stathmin 
may play a role during liver regeneration. 
We show here that the stathmin gene is apparently 
repressed in the adult liver, but is de-repressed when 
parenchymal cell growth was induced by partial hepat- 
ectomy. The stathmin mRNA upregulation during liver 
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regeneration supports the hypothesis that stathmin is a 
growth-ass~iated protein. Our results also indicate that 
liver regeneration provides a model to study the mecha- 
nisms of plastic genetic response of stathmin and its 
role(s) in cellular proliferation. 
2. MATERIALS AND METHODS 
2.1. Animals und partial hepatectomy 
The C57BL mice were used in both development and liver regener- 
ation experiments. They were fed ad libitum under a 12 h/12 h light- 
dark cycle. Embryos and pups were sacrificed at E15, E19, PO, P4, P8, 
P14, P25 (n B 2). Three month-old mice were used as adult controls. 
Partial hepatectomy and sham operations were performed as de- 
scribed for rats [ 111 on male and female C57BL mice (age: 3-6 months 
old). The mice were ether anesthetized and subjected to midventral 
laparotomy with approximately 70% liver resection (ieft lateral and 
median lobes). Mice were sacrificed at 1, 3, 6, 18, 24, 36,48 h and 2, 
4, 6, 10 days (n = 2) post-operation. The liver was excised, cut into 
several pieces, and quickly frozen in dry ice-ethanol. Half of the tissue 
was used for RNA isolation, and half for in situ hybridization. 
2.2. RNase protection assay and Northern blot hybridization 
RNase protection was performed as previously described [1 51 using 
“P-labeled RNA probes. For quantitation of stathmin mRNA in 
mouse tissues, a ~~ndIII-truncated probe was generated using the 
pCP724 subclone that contained a portion of the second intron and 
the third exon (71. Control probes were generated by truncation of a 
mouse phospho~ycera~ kinase (PGK) cDNA [16] and a human y- 
actin cDNA (see [ 151) with Sag3A and H&d?, respectively. All anti- 
sense probes were synthesized with SP6 RNA polymerase in the pres- 
ence of 800 Cilmmol [?]UTP @uPont/NEN). Full-length probes 
were purified by polyacrylamide gel electrophoresis. Hybridization 
with 10 pg of total cellular RNA was carried out at 50°C in the 
presence of 10 pg of Escherichia coli tRNA as carrier in a 30~1 reaction 
volume containing 80% formamide and 40 mM PIPES buffer (pH 6.4). 
After 12 h of incubation, digestion was carried out with RNase Tl 
(BRL). Protected fragments were resolved on 4% polyacrylamide se- 
quencing gels containing 7.5 M urea. Radiolabeled size markers were 
generated by the end-labeling of EcoRI-Hinff double digest of 
pBR322 using Klenow fragment in the presence of [35SwTP (800 
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CiZmmol, DuPontZNEN). Intensities of the protected fragments were 
quantitated on autoradiograms with a densitometer (Bio-Rad, model 
GS-670). Northern blot hybridization was performed as described 
previously [18]. c-j& cDNA was a gift from Dr. P. Vogt, and the insert 
was subcloned into pGEM3. A full-length tumor growth factor 
TGFBl clone, which was a gift from Dr. N. Nicols, was cut and a 
portion of unique region (nucleotide residues 617-1,345) was sub- 
cloned intto pGEM3. 
2.3. In situ hybridization 
Whole bodies of embryo and pups were frozen in powdered dry ice. 
Whole body (15 pm) and liver sections (13 Ann) were cut on a cryostat 
(Hacker Instruments), then mounted onto gelatin coated slides, and 
stored at -80°C until use. The sections were post-fixed, acetylated, 
dehydrated, and hybridized as previously described [17,18]. Sections 
were hybridized with 3SS-labeled sense or antisense cRNA probe. Pho- 
tographs were taken using the X-ray film image as a negative, and 
emulsion-dipped slides. 
3. RESULTS 
3.1. Stathmin mRNA expression in the liver of embry- 
onic and prenatal animals 
A representative expression profile of stathmin 
mRNA as assayed by in situ hybridization in whole 
body sections at post-natal day 5 (P5) mouse is pre- 
sented as Fig. 1. Stathmin mRNA is abundant in nerv- 
ous tissues including brain, spinal cord, as well as pe- 
ripheral ganglia, e.g. dorsal root ganglia. In situ hybrid- 
ization with stathmin sense probe showed negligible sig- 
nals (not shown). Stathmin mRNA expression was high 
in neural tissues from El5 and El9 embryos (data not 
shown), and peaked between late gestation to early 
post-natal days in the rat [19]. Other non-neuronal tis- 
sues also expressed significant amounts of this mRNA 
during these periods. Notably, developing thymus ex- 
pressed very high levels of stathmin mRNA, while em- 
bryonic (not shown) and post-natal (see Fig. 1) liver 
expressed moderate levels. 
3.2. Apparent repression f stathmin mRiVA expression 
in the adult liver 
Stathmin mRNA is expressed in embryonic and early 
Fig. 1. Stathmin mRNA expression during development. Shown is an 
in situ hybridization image of stathmin mRNA in a post-natal day 5 
mouse whole mount senction. Note strong signals are seen in neural 
tissues, i.e. olfactory bulb (Ob), cerebral cortex (Ctx), cerebellum (Cb), 
spinal cord (Sp) and dosal root ganglia (Drg), as well as thymus (Tm), 
while low levels of signals are seen in other tissues including thyroid 
(Tr), heart (Ht), intestine (In), and liver (Lv). Bar = 5 mm. 
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Fig. 2. Stathmin mRNA expression in adult tissues. Probes used for 
the three sets of experiments: (A) pl9/stathmin, (B) PGK, and (C) 
y-actin, were run unhybridized in lanes 1, 2, and 12, respectively. 
RNase protection experiments were carried out with carrier tRNA 
only (lane 3), or RNAs from cells and tissues: Cl300 cells (lane 4). 
NIH-3T3 cells (lane 5), testis (lane 6), liver (lane 7), kidney (lane 8), 
spleen (lane 9), heart (lane lo), and brain (lane 11). Sixes of the probes 
and protected fragments are given at the right side of each panal. Note 
that the sixes of protected fragments are slightly larger than the corre- 
sponding sequences because only RNase Tl was used to digest unhy- 
bridized cRNA. Size markers were 35S-labeled EcoRI-Hinff double 
digests of pBR322. 
post-natal mouse liver but is not detected in the adult 
liver (Fig. 2). We carefully determined the expression 
levels of stathmin in mouse tissues and cells by RNase 
protection assays. Using a 420 nt-long probe which con- 
tains a part of intron 2 and exon 3, a 170 nt-long RNA 
was protected in brain, testis, heart, spleen and kidney, 
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Fig. 3. Repression of stathmin mRNA expression during post-natal development and de-repression during liver regeneration. Upper and lower 
panels show RNase protection profiles of stathmin and phosphoglycerate kinase (PGK) mRNAs and quantitation of stathmin mRNA levels 
compared with the PGK mRNA levels. (A) Stathmin mRNA levels decrease during post-natal development. Lane 1, tRNA only; lanes 2-7, mouse 
liver RNA from post-natal day 0,4, 8, 14, 25 and 60; lanes 8 and 9, probe only (no hybridization nor digestion). (B) Stathmin mRNA is induced 
during liver regeneration. Lane 1, control mouse liver RNA; lanes 2-7, liver RNA from 1, 3,6,18,24,36,48 h post-operation; lanes 8 and 9, probe 
only (no hybridization nor digestion). Size markers are as indicated in Fig. 2. 
but not liver total RNA (Fig. 2A). Since the RNase 
protection assay is highly sensitive and discriminates 
cross-hybridization with other RNAs, including 
rRNAs, these results strongly suggest that the normal 
adult liver does not express tathmin mRNA. Quantita- 
tion by laser densitometory indicated that the brain and 
testis expressed at least 4-fold more transcripts than 
other moderately expressing tissues, such as heart, 
spleen and kidney (data not shown). Similarly, the 
mouse neuroblastoma Cl 300 expressed 4-fold more 
transcripts than NIH-3T3 fibroblasts (Fig. 2A). Tran- 
scripts of phosphoglycerate kinase (PGK) and y-actin, 
used as controls, were more evenly distributed among 
the various tissues and cells examined (Fig. 2B,C). 
These results indicate that the stathmin gene is actively 
transcribed during development, but its expression 
ceases or may become repressed at some time during 
post-natal development. 
To determine when stathmin mRNA expression de- 
clined during post-natal development, we measured the 
mRNA levels by the RNase protection assay (Fig. 3A). 
Stathmin mRNA diminished gradually during this pe- 
riod and decreased by more than 90% by P25 when 
compared to the newborn level. Thus, stathmin mRNA 
expression ceased by about 1 month after birth, which 
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corresponds to hepatocytes becoming post-mitotic. This 
suggests that stathmin expression correlates with matu- 
ration, i.e. completion of differentiation or prolifera- 
tion. 
3.3. De-repression of stathmin gene expression during 
liver regeneration 
Since stathmin expression is commonly observed in 
rapidly growing tissues and cells, i.e. developing brain, 
thymus (see Fig. l), cytokine-induced T-cells, and 
tumor cells [12-141, we determined whether stathmin 
mRNA expression can be induced in partially hepatec- 
tomized mice. We measured stathmin mRNA levels in 
the liver at various times after surgery. By 24 h stathmin 
mRNA was undetectable, however, it rapidly increased 
by 2-3 days post-operation to the level of newborn 
animals (Fig. 3B). Northern blot hybridization experi- 
ments showed that the sizes of the induced mRNA was 
the same as that in newborn liver and brain (i.e. 1 kb 
and 3 kb) (data not shown). In situ hybridization exper- 
iments revealed that the stathmin mRNA was induced 
in hepatocytes (Fig. 4). Only background levels of the 
mRNA encoding SCGlO, a neural-specific isoform of 
stathmin, were detected in either control or regenerating 
liver (data not shown). 
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Fig. 4. Stathmin mRNA is induced in regenerating hepatocytes. 
Shown are sections hybridized with stathmin antisense probe; liver 
sections of control mouse (A,B) and day 6 after partial hepatectomy 
(C,D). Photomicrographs were taken under bright-field (A,C) and 
dark-field (B,D) illumination. Bars = 70 pm. 
Stathmin mRNA induction in regenerating liver oc- 
curred 24 h after partial hepatectomy. The kinetics of 
this induction is rather slow in comparison to other 
genes that are involved in liver regeneration. For exam- 
ple, the mRNA of the so-called immediate-early gene 
[20], c-fis, was transiently up-regulated by 1 h post- 
surgery (data not shown). Messenger RNA encoding 
TGF/31 that acts on differentiation and regeneration in 
a variety of tissues [21,22] and is involved in repressing 
DNA synthesis in regenerating liver [23], appeared at 
low but significant levels 6 days after surgery (data not 
shown). Thus, stathmin appears to be a slow-respond- 
ing gene but may not be a late-responding ene. 
4. DISCUSSION 
Our results demonstrate that the mRNA encoding the 
19 kDa phosphoprotein, stathmin, is induced in adult 
regenerating liver [ 1,2]. The induction is not an immedi- 
ate response but correlates with the growth and prolifer- 
ation of hepatocytes. Stathmin mRNA induction in re- 
generating liver serves as an excellent example of the 
correlation of its expression and cellular proliferation 
[ 1,12-141. Stathmin may not be involved in the matura- 
tion of liver cell function, since its mRNA induction 
decreases by day 10 post-surgery. Direct correlation of 
the stathmin gene expression and cellular proliferation 
suggests that stathmin may be involved in cell cycle 
control. Recent evidence that stathmin is 
phosphorylated by MAP kinase and p34cdc2 kinase 
[24,25] and that it is expressed and phosphorylated in 
Xenopus oocytes [8] favours this idea. It will be of inter- 
est to examine whether the stathmin protein levels and 
the degree of its phosphorylation change during liver 
regeneration. 
The precise mechanism of stathmin gene induction 
during liver regeneration is unknown. Since stathmin 
mRNA is undetected in normal adult liver, its induction 
may involve transcriptional activation. The proximal 
promoter region (-730 bp) of the mouse stathmin gene 
can activate transcription in vitro in nuclear extracts 
prepared from adult mouse liver (T. Okazaki and Y. 
Nakanishi, unpublished observation), which suggests 
that a transcriptional silencer(s) may exist further up- 
stream or downstream of the promoter region, as in the 
case of the SCGlO gene [15,26], the neural-specific ho- 
molog of stathmin. Understanding the precise mecha- 
nisms of stathmin gene induction during liver regenera- 
tion requires further analysis of transcriptional regula- 
tion. 
Stathmin gene expression is induced by cellular 
growth stimulation, but it is also induced by certain 
types of cell death. Our preliminary experiments indi- 
cated that stathmin and its mRNA are significantly in- 
duced in hippocampal neurons that were treated by 
colchicine injection [28]. Cellular proliferation and 
death may therefore share some common mechanisms, 
and stathmin may locate at one of those processes. 
Stathmin may play different or multiple roles in dif- 
ferent tissues. For example, stathmin expression occurs 
at high levels in tissues that contain proliferating cells 
[4,12,13], but it is also highly expressed in post-mitotic 
neurons [ 18,191. Indeed, the massive xpression of stath- 
min mRNA in developing central and peripheral nerv- 
ous systems (see Fig. 1) would suggest that stathmin 
plays a different role(s) in nervous tissues than merely 
cellular proliferation. It may, for example, work for 
neuronal growth as SCGlO does in developing neurons, 
while it may also play a role in signal transduction 
processes in neurons. In the brain it has been shown that 
mRNAs encoding SCGlO and stathmin are expressed 
in different subset neurons. Stathmin is preferentially 
expressed in short process-bearing neurons, while 
SCGlO is more abundantly expressed in neurons with 
long processes, large terminal fields, or extensive den- 
drites [18]. Thus, stathmin seems to have a role in post- 
mitotic neurons probably for neuronal differentiation 
and plasticity, which is independent of the role for cellu- 
lar proliferation. 
The molecular signals controlling liver regeneration 
are being rapidly defined. Several growth factors, such 
as epidermal growth factor (EGF), TGF&, acidic fi- 
broblast growth factor (aFGF) and hepatocyte growth 
factor (HGF), have been defined as mitogens for hepa- 
tocyte growth [27]. In contrast to those growth factors, 
the role of TGF/?l in inhibiting the growth of parenchy- 
ma1 cells is also of importance for the cessation of liver 
growth to complete the regeneration [23]. The induction 
of stathmin mRNA occurs between the transient induc- 
tion of the immediate-responding genes and the increase 
in TGFbl, serving as a new marker of this plastic 
growth response seen in the liver. It is a future interest 
to determine signals and factors controlling the stath- 
min gene induction both in the liver and the brain, 
which preserve a remarkable plasticity of growth re- 
sponses. 
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